GlassScriptPhysician profile
Brigette Bailey Rabitsch
NPI 1144243296
$3,262.75
in general payments reported to CMS, 2019-2025
20 companies · $445 in 2025
The $445 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $326 · 2021: $435 · 2022: $635 · 2023: $457 · 2024: $527 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,362 · Gift: $66.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,361.83 |
| Gift | $66.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $542.91 | 2022-2025 | Infuse, Miebo, Vyzulta |
| Alcon Vision LLC | $521.43 | 2019-2025 | Precision 1, Tryptyr, Rocklatan |
| Allergan, INC. | $273.16 | 2019-2022 | |
| Oyster Point Pharma, INC. | $267.60 | 2022-2024 | Tyrvaya |
| Abbvie INC. | $238.16 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $194.39 | 2020-2023 | Cequa |
| Coopervision INC. | $160.13 | 2019-2023 | Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $135.52 | 2019 | |
| Novartis Pharmaceuticals Corporation | $131.72 | 2019-2022 | |
| Harrow Eye, LLC | $119.80 | 2024-2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $113.39 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $109.98 | 2021-2025 | Oxervate |
| Shire North American Group INC | $106.37 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $90.40 | 2019-2025 | |
| Tearlab Corp | $66.86 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $55.97 | 2025 | Tepezza |
| Biotissue Holdings INC. | $53.52 | 2019-2024 | |
| Kala Pharmaceuticals, INC. | $46.49 | 2021-2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sight Sciences, INC. | $15.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brigette Rabitsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.